Pfizer allocates 2 billion vaccine doses to poorer countries through COVAX

Pfizer and BionTech will deliver through the international vaccine-sharing facility COVAX some of the 2 billion COVID-19 vaccine doses it announced on Friday as new supplies for low- and middle-income countries.

The doses will be allocated “through bilateral agreements, agreements with supranational organizations as well as our partnership with COVAX,” a Pfizer spokesman said.

Get breaking National news

For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen.

Sign up for breaking National newsletter Sign Up

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

Earlier on Friday a BioNTech spokeswoman said: “We are currently still evaluating this.”

1:03 Canada remains ‘committed’ to COVAX vaccine-sharing program, Trudeau says